Plasma interleukin-1β concentrations are closely associated with fasting blood glucose levels in healthy and preclinical middle-aged nonoverweight and overweight Japanese men

Metabolism: Clinical and Experimental

Volumn 59, Issue 10, 2010, Pages 1465-1471

  Misaki, Yasumi ^a   Miyauchi, Rie ^a   Mochizuki, Kazuki ^a   Takabe, Satsuki ^a   Shimada, Masaya ^a   Ichikawa, Yoko ^a   Goda, Toshinao ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRIACYLGLYCEROL; CYTOKINE; GLUCOSE BLOOD LEVEL;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FASTING GLUOSE BLOOD LEVEL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INTERLEUKIN 1BETA BLOOD LEVEL; JAPANESE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ANALYSIS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; DIET RESTRICTION; HEALTH; METABOLISM; MIDDLE AGED; OSMOLARITY; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; CYTOKINES; FASTING; HEALTH; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; OBESITY; OSMOLAR CONCENTRATION; OVERWEIGHT;

EID: 77956947666     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.01.011     Document Type: Article

References (37)

1. Vettor R., Milan G., Rossato M., and Federspil G. Review article: adipocytokines and insulin resistance Aliment Pharmacol Ther 22 Suppl 2 2005 3 10
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
3. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited Arterioscler Thromb Vasc Biol 24 2004 816 823
4. Spranger J., Kroke A., Mohlig M., and Hoffmann K. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study Diabetes 52 2003 812 817
5. Kim E.S., Im J.A., Kim K.C., and Park J.H. Improved insulin sensitivity and adiponectin level after exercise training in obese Korean youth Obesity (Silver Spring) 15 2007 3023 3030
6. Bruun J.M., Stallknecht B., Helge J.W., and Richelsen B. Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss Eur J Endocrinol 157 2007 465 471
7. Loweth A.C., Williams G.T., James R.F., and Scarpello J.H. Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1β and Fas ligation Diabetes 47 1998 727 732
8. Montolio M., Biarnes M., Tellez N., and Escoriza J. Interleukin-1β and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation J Endocrinol 192 2007 169 177
9. Hoge M., and Amar S. Role of interleukin-1 in bacterial atherogenesis Drugs Today (Barc) 42 2006 683 688
10. Mahmoudi M., Curzen N., and Gallagher P.J. Atherogenesis: the role of inflammation and infection Histopathology 50 2007 535 546
11. Shoelson S.E., Lee J., and Goldfine A.B. Inflammation and insulin resistance J Clin Invest 116 2006 1793 1801
12. Bastard J.P., Jardel C., Bruckert E., and Blondy P. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss J Clin Endocrinol Metab 85 2000 3338 3342
13. Yudkin J.S., Kumari M., Humphries S.E., and Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link Atherosclerosis 148 2000 209 214
14. Deepa R., Velmurugan K., Arvind K., and Sivaram P. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance-the Chennai Urban Rural Epidemiology Study (CURES) Metabolism 55 2006 1232 1238
15. Motton D.D., Keim N.L., Tenorio F.A., and Horn W.F. Postprandial monocyte activation in response to meals with high and low glycemic loads in overweight women Am J Clin Nutr 85 2007 60 65
16. Taniguchi A., Fukushima M., Ohya M., and Nakai Y. Interleukin 6, adiponectin, leptin, and insulin resistance in nonobese Japanese type 2 diabetic patients Metabolism 55 2006 258 262
17. Matsushita K., Yatsuya H., Tamakoshi K., and Wada K. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men Arterioscler Thromb Vasc Biol 26 2006 871 876
18. Murakami K., Mizoue T., Sasaki S., and Ohta M. Dietary intake of folate, other B vitamins, and omega-3 polyunsaturated fatty acids in relation to depressive symptoms in Japanese adults Nutrition 24 2008 140 147
19. Haffner S.M., Greenberg A.S., Weston W.M., and Chen H. Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus Circulation 106 2002 679 684
20. Andreozzi F., Laratta E., Cardellini M., and Marini M.A. Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects Diabetes 55 2006 2021 2024
21. Vozarova B., Weyer C., Hanson K., and Tataranni P.A. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion Obes Res 9 2001 414 417
22. Salmenniemi U., Ruotsalainen E., Pihlajamaki J., and Vauhkonen I. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome Circulation 110 2004 3842 3848
23. Mohamed-Ali V., Goodrick S., Rawesh A., and Katz D.R. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo J Clin Endocrinol Metab 82 1997 4196 4200
24. Jorns A., Gunther A., Hedrich H.J., and Wedekind D. Immune cell infiltration, cytokine expression, and β-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-IDDM rat Diabetes 54 2005 2041 2052
25. Maedler K., and Donath M.Y. β-Cells in type 2 diabetes: a loss of function and mass Horm Res 62 Suppl 3 2004 67 73
26. Larsen C.M., Faulenbach M., Vaag A., and Ehses J.A. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes Diabetes Care 32 2009 1663 1668
27. Larsen C.M., Faulenbach M., Vaag A., and Volund A. Interleukin-1-receptor antagonist in type 2 diabetes mellitus N Engl J Med 356 2007 1517 1526
28. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family Annu Rev Immunol 27 2009 519 550
29. Fukaya N., Mochizuki K., Shimada M., and Goda T. The α-glucosidase inhibitor miglitol decreases glucose fluctuations and gene expression of inflammatory cytokines induced by hyperglycemia in peripheral leukocytes Nutrition 25 2009 657 667
30. Tanaka Y., Mochizuki K., Fukaya N., and Shimada M. The α-glucosidase inhibitor miglitol suppresses postprandial hyperglycaemia and interleukin-1β and tumour necrosis factor-α gene expression in rat peripheral leucocytes induced by intermittent sucrose loading Br J Nutr 102 2009 221 225
31. Fujimoto S., Mochizuki K., Shimada M., and Murayama Y. Variation in gene expression of inflammatory cytokines in leukocyte-derived cells of high-fat-diet-induced insulin-resistant rats Biosci Biotechnol Biochem 72 2008 2572 2579
32. Dasu M.R., Devaraj S., and Jialal I. High glucose induces IL-1β expression in human monocytes: mechanistic insights Am J Physiol Endocrinol Metab 293 2007 E337 346
33. Lachmann H.J., Lowe P., Felix S.D., and Rordorf C. In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes J Exp Med 206 2009 1029 1036
34. Kallio P., Kolehmainen M., Laaksonen D.E., and Pulkkinen L. Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individuals with the metabolic syndrome Am J Clin Nutr 87 2008 1497 1503
35. Wannamethee S.G., Whincup P.H., Thomas M.C., and Sattar N. Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk Diabetes Care 32 2009 1823 1825
36. Ma Y., Hebert J.R., Li W., and Bertone-Johnson E.R. Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study Nutrition 24 2008 941 949
37. Lopez-Garcia E., Schulze M.B., Fung T.T., and Meigs J.B. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction Am J Clin Nutr 80 2004 1029 1035